STAT6 and metastatic colorectal cancer: Another ongoing phase I trial being performed on patients with metastatic colorectal cancers involves exosomes loaded with a synthetic lipid-tagged Stat6 antisense oligonucleotide: exoASO-STAT6 (CDK-004) (Table 3).